Methotrexate and sulphasalazine combination trial (MASCOT): The impact of initial response to standard monotherapy on 5 year clinical responseL. Waite, J. Dale,R. Hampson,A. Tierney, H. Nicholas, R. Madhok,H. A. CapellANNALS OF THE RHEUMATIC DISEASES（2007）引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
